Brintellix

Brintellix belongs to Lundbeckfonden through H. Lundbeck A/S. Brintellix is owned by Lundbeckfonden, headquartered in Denmark. No. The ultimate owner of Brintellix, Lundbeckfonden, is headquartered in Denmark, not in the United States.

H. Lundbeck A/S is a global pharmaceutical company specialized in brain diseases, including depression, schizophrenia, Parkinson's disease, and Alzheimer's disease.

Lundbeck Portugal - Produtos Farmacêuticos, Lda.